- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 15, 2024 | 71.38M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 67.66M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 53.83M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $364K |
| Capex | Q1 2024 · Mar 31, 2023 | $23K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$9.16M |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$5.63M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $78.69M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $754K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $1.89M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$60.61M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$59.64M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | −$99.51M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | −$88.31M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $21.68M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $22.15M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $102.82M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $101.84M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $2.99M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $3.34M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $42.21M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $42.21M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.10 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$0.21 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.10 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$0.21 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $1.3M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $654K |
| Net Income | Q1 2024 · Mar 31, 2024 | −$6.48M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$11.23M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$4.05M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$2.62M |
| Revenue | Q1 2024 · Mar 31, 2024 | $5.82M |
| Revenue | Q1 2024 · Mar 31, 2023 | $4.46M |